Explore our safety modules.
Explore each safety module, including the science behind it, its current regulatory status, and a direct path to our team.
A medicine must do two things: be safe and effective. For centuries we have relied on animal models to answer those questions. We build AI better representative of human biology — to replace animal experiments.
$2B
Cost per drug
Average cost to bring a single new drug to market.
2
Root causes
Lack of efficacy and unforeseen safety — both failures of prediction.
90%
Never approved
Of candidates that enter Phase I, the share that never reach approval.
A multimodal foundation model trained on vast biological data, with robust uncertainty — that learns and explains the mechanism behind every prediction.
ARCHITECTURE
Mechanism meets machine learning
A causal backbone grounds the model in biology; a data-driven layer learns what the rules can’t yet describe; and calibrated uncertainty makes every prediction interpretable — down to the individual patient.
Mechanism
Grounded in the biology of how injury actually occurs.
Learning
Learns the patterns mechanism alone can’t capture.
Precision
Calibrated uncertainty, tuned to person and context.

The liver is the body’s chemical interface — the first-pass filter for nearly everything we ingest, and the organ most often behind a withdrawn drug.
When will the liver be injured?
For a given molecule and context, the Digital Liver predicts the conditions under which the liver is injured — combinatorial risk that no animal or simple lab model can catch.
Safety intelligence, modernized.
Multi-endpoint optimization with supported evidence — extending beyond the liver to cardiotoxicity, renal toxicity, and more.
FDA ISTAND
Regulatory milestone
Accepted into the FDA’s ISTAND program to help predict drug-induced liver injury — the first in-silico tool of its kind that regulators and drug developers can rely on during development.








